Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | MLYCD | O95822 | 2/20 | 0.49 |
| ▸ | GSK3B | P49841 | 2/20 | 0.48 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.44 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7887114 | 0.80 | CA2 (0.53) | CA2CA1MLYCDGSK3BPARP15 | |
| SCHEMBL27152949 | 0.78 | GSK3B (0.44) | CA2CA1MLYCDGSK3BPARP15 | |
| SCHEMBL7368558 | 0.78 | MLYCD (0.73) | CA2CA1MLYCDGSK3BPARP15 | |
| Water SCHEMBL733811 | 0.76 | CES1 (0.56) | CA2CA1KMT2AMEN1ALDH1A1 | |
| Water SCHEMBL27561426 | 0.76 | CES1 (0.56) | CA2CA1KMT2AMEN1ALDH1A1 | |
| Water SCHEMBL19283519 | 0.76 | CES1 (0.56) | CA2CA1KMT2AMEN1ALDH1A1 | |
| SCHEMBL216706 | 0.76 | CA2 (0.64) | CA2CA1GSK3BPARP15PARP10 | |
| Water SCHEMBL18124365 | 0.76 | CES1 (0.56) | CA2CA1KMT2AMEN1ALDH1A1 | |
| SCHEMBL1225921 | 0.76 | CA2 (0.53) | CA2CA1MLYCDGSK3BPARP15 | |
| SCHEMBL10940932 | 0.76 | CA1 (0.48) | CA2CA1MLYCDGSK3BPARP15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0935748-B1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RES & DEV (IL) | 2003-10-29 | — | — | EP | claimed |
| US-6433356-B1 | Hybrid organic-inorganic semiconductor structures and sensors based thereon | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2002-08-13 | — | — | US | claimed |
| EP-0935748-A1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RESEARCH & DEVELOPMENT COMPANY, LTD. (IL) | 1999-08-18 | — | — | EP | claimed |
| WO-1998019151-A1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1998-05-07 | — | — | WO | claimed |
| CN-116715663-A | Preparation method of non-neridrone and intermediate thereof | 奥锐特药业股份有限公司 | 2023-09-08 | — | — | CN | disclosed |
| EP-3473625-B1 | PREPARATION METHOD FOR CHIRAL PYRROLOPYRIMIDINE COMPOUND | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2021-06-02 | — | — | EP | disclosed |
| US-10766901-B2 | Preparation method for chiral pyrrolopyrimidine compound | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2020-09-08 | — | — | US | disclosed |
| US-20190211021-A1 | Preparation Method For Chiral Pyrrolopyrimidine Compound | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2019-07-11 | — | — | US | disclosed |
| EP-3473625-A1 | PREPARATION METHOD FOR CHIRAL PYRROLOPYRIMIDINE COMPOUND | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2019-04-24 | — | — | EP | disclosed |
| US-20090224820-A1 | MOLECULAR CONTROLLED SEMICONDUCTOR DEVICE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2009-09-10 | — | — | US | disclosed |
| US-7488991-B2 | Molecular controlled semiconductor device | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2009-02-10 | — | — | US | disclosed |
| US-7118861-B1 | DNA detector based on molecular controlled semiconductor resistor | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2006-10-10 | — | — | US | disclosed |
| US-20060118903-A1 | Molecular controlled semiconductor device | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2006-06-08 | — | — | US | disclosed |
| EP-1425411-A4 | DNA DETECTOR BASED ON MOLECULAR CONTROLLED SEMICONDUCTOR RESISTOR | YEDA RES & DEV (IL) | 2004-06-23 | — | — | EP | disclosed |
| EP-1425411-A2 | DNA DETECTOR BASED ON MOLECULAR CONTROLLED SEMICONDUCTOR RESISTOR | YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) | 2004-06-09 | — | — | EP | disclosed |
| EP-0935748-B1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RES & DEV (IL) | 2003-10-29 | — | — | EP | disclosed |
| US-6433356-B1 | Hybrid organic-inorganic semiconductor structures and sensors based thereon | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2002-08-13 | — | — | US | disclosed |
| WO-2000075276-A2 | DNA DETECTOR BASED ON MOLECULAR CONTROLLED SEMICONDUCTOR RESISTOR | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2000-12-14 | — | — | WO | disclosed |
| EP-0935748-A1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RESEARCH & DEVELOPMENT COMPANY, LTD. (IL) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998019151-A1 | HYBRID ORGANIC-INORGANIC SEMICONDUCTOR STRUCTURES AND SENSORS BASED THEREON | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1998-05-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211021-A1 | Preparation Method For Chiral Pyrrolopyrimidine Compound | DHPS, DPYD, MPHOSPH6 | CA2 1403/4885CA1 1842/4885MLYCD 3558/4885 |
| US-10766901-B2 | Preparation method for chiral pyrrolopyrimidine compound | DHPS, DPYD, MPHOSPH6 | CA2 1403/4885CA1 1842/4885MLYCD 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.